- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05879094
Orthopaedic Simulation of Morton's Extension to Test the Effect on Plantar Pressures of Each Metatarsal Head in Patients Without Deformity: A Pre-post-test Study.
June 2, 2023 updated by: EVA MARIA MARTÍNEZ JIMENEZ, Mayuben Private Clinic
The aim of this study is to simulate the orthopedic treatment called Morton's extension on non-deformed patients to check the effects on each metatarsal head on its static footprint.
Study Overview
Detailed Description
The objective of this study is to perform an assimilation of the orthopedic treatment called morton extension on non-deformed patients to verify the effects on each metatarsal head on its static footprint, specifically the mean pressures and before and after the application of the morton extension.
Study Type
Interventional
Enrollment (Actual)
25
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Madrid, Spain, 28040
- Eva María Martínez-Jiménez
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- no history of trauma to the foot;
- the presence of at least 10° of dorsiflexion at the ankle with the knee fully dorsiflexed;
- unrestricted motion of the functional subtalar joint of 30°;
- unrestricted motion along the longitudinal axis of the midtarsal joint of 15°;
- unrestricted nonweight-bearing motion of the first ray of at least 8 mm;
- greater than 50° of dorsiflexion of the hallux to the first metatarsal bisection during nonweight-bearing;
- age greater than 18 years and younger than 60 years;
- at the time of data collection, no lower limb dysfunction or chronic injury; and
- no evidence of a non-fixed deformity at first MTP and first metatarsal cuneiform joints.
Exclusion Criteria:
- plantar corns and calluses,
- hallux valgus and lesser toe deformities,
- diabetes,
- any abnormality in the lower extremity that may affect gait.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Morton extension
Experimental group con Morton Extension application
|
A Morton extension with a height of 5 mm was insert from the proximal area of the first metatarsal head to the base of the proximal phalanx of the Hallux of the subjects' bare feet using a paper bandage.
The material, shape, size, and thickness of the Morton Extension were the same.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Before Morton Extension Medium pressure
Time Frame: Through study completion, an average of 1 week
|
Static footprint will measure medium plantar pressures of first, second third fourth fifth and midfoot rearfoot and forefoot in Kilopascals (KPa).
Subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline.
|
Through study completion, an average of 1 week
|
|
Before Morton Extension Maximum pressure
Time Frame: Through study completion, an average of 1 week
|
Static footprint will measure maximum plantar pressures of first, second third fourth fifth and midfoot rearfoot and forefoot in Kilopascals (KPa).
Subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline.
|
Through study completion, an average of 1 week
|
|
After Morton Extension Medium pressure
Time Frame: Through study completion, an average of 1 week
|
Static footprint will measure medium plantar pressures of first, second third fourth fifth and midfoot rearfoot and forefoot in Kilopascals (KPa).
Subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline.
|
Through study completion, an average of 1 week
|
|
After Morton Extension Maximum pressure
Time Frame: Through study completion, an average of 1 week
|
Static footprint will measure maximum plantar pressures of first, second third fourth fifth and midfoot rearfoot and forefoot in Kilopascals (KPa).
Subjects were instructed to stand barefoot on the force platform, participants were instructed to remain in a relaxed standing posture with feet shoulder-width apart and positioned at 30º away from the midline.
|
Through study completion, an average of 1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Eva María Martínez-Jimenez, PhD, Mayuben Private Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 29, 2023
Primary Completion (Actual)
May 31, 2023
Study Completion (Actual)
June 2, 2023
Study Registration Dates
First Submitted
May 18, 2023
First Submitted That Met QC Criteria
May 18, 2023
First Posted (Actual)
May 30, 2023
Study Record Updates
Last Update Posted (Actual)
June 5, 2023
Last Update Submitted That Met QC Criteria
June 2, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20/235-E
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Subjects
-
BiogenCompletedHealthy Adult Subjects | Healthy Elderly SubjectsUnited States
-
PfizerCompletedHealthy Adult Subjects and Healthy Elderly SubjectsBelgium
-
PfizerCompletedHealthy Subjects | Healthy ParticipantsUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHealthy | Healthy Subjects | ImmunosuppressionUnited States
-
Lund UniversityCompletedHealthy Subjects | Diet, HealthySweden
-
Vichy LaboratoiresCentre de Pharmacologie Clinique Applique a la DermatologieCompletedHealthy Subjects | Healthy AdultFrance
-
Yuhan CorporationNot yet recruiting
-
Central Hospital, Nancy, FranceRecruitingHealthy SubjectsFrance
-
Lutroo Imaging LLCStanford UniversityRecruiting
Clinical Trials on Morton extension
-
Mayuben Private ClinicUniversidad de LeónCompleted
-
Mayuben Private ClinicUniversidad Complutense de MadridCompleted
-
NYU Langone HealthNot yet recruitingEnd Stage Kidney DiseaseUnited States
-
Texas Tech University Health Sciences CenterCompleted
-
Tanta UniversityNot yet recruitingSeptal Extension Graft in Rhinoplasty | Primary Rhinoplasty | Nasal ProjectionEgypt
-
Universidad Miguel Hernandez de ElcheNot yet recruitingHealthy Adult Volunteer | Exercise Induced HypoalgesiaSpain
-
Children's Hospital Medical Center, CincinnatiRush UniversityCompletedSleep | Dietary Habits | Circadian Rhythm DisordersUnited States
-
Riphah International UniversityCompleted
-
Merrimack CollegeNational Institute of Mental Health (NIMH)Recruiting
-
Head and Neck Cancer International GroupCompletedHead and Neck Squamous Cell Carcinoma | Extranodal Extension | Human Papilloma Virus Related CarcinomaSwitzerland, United Kingdom, United States, Germany, Australia, France, Spain, Denmark